News

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
FDA approves Moderna’s new lower-dose COVID-19 vaccine
The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
How Moderna Went From Pandemic Hero to Vaccine Victim
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
KSL6d
FDA approves Moderna's next-generation COVID vaccine for adults 65 and older
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
Clinical Advisor1d
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
FDA grants limited approval to new Covid vaccine from Moderna
Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...
Moderna's new lower-dose COVID-19 vaccine approved by FDA
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...
Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...
Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine
Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Wall Street Journal4d
How Moderna Went From Pandemic Hero to Vaccine Victim
Hopkins In the latest setback for Moderna, the Food and Drug Administration on Friday approved its next-generation Covid shot for a narrower population of patients than the company intended.